Sales rise 45.56% to Rs 17.22 crore
Net profit of Sandu Pharmaceuticals rose 73.91% to Rs 0.40 crore in the quarter ended September 2020 as against Rs 0.23 crore during the previous quarter ended September 2019. Sales rose 45.56% to Rs 17.22 crore in the quarter ended September 2020 as against Rs 11.83 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales17.2211.83 46 OPM %3.433.97 -PBDT0.690.49 41 PBT0.550.35 57 NP0.400.23 74Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
